Santhosh Reddy Meedimale, Consultant Medical Oncologist at Omega Hospitals, shared a post on LinkedIn:
“Honored and proud to have presented my research at the ESMO – European Society for Medical Oncology Lung Cancer Congress 2026 in Copenhagen, Denmark(March 25–28).
As one of the most prestigious global platforms in thoracic oncology, ELCC brings together leaders shaping the future of lung cancer care. Presenting my work in person at such a forum is truly a meaningful milestone in my academic journey.
Our study highlights the prognostic significance of circulating interleukins in ALK-rearranged advanced lung cancer, reinforcing the role of inflammatory biomarkers in refining patient outcomes.
A heartfelt thank you to Omega Hospitals and my mentors for their constant support and guidance throughout this journey. Grateful for this opportunity and inspired to continue contributing to the evolving field of thoracic oncology.”
New Frontiers in Thoracic Oncology: Insights from Dr. Haiquan Chen